Cell & Gene Therapy Innovation Speaker

BryanDeane.jpeg

Mio Muelthaler

Director, Business Development, Europe

Mio Muelthaler is on a mission to spread the news about a new fascinating disruptive nanofluidics based single-cell technology for gene therapy in EU. He joined in December 2017 Berkeley Lights – a innovative start-up in the bay area / California delivering breakthrough platforms and devices that fundamentally change the way biological processes are done - as Director, Business Development Europe. After almost 2 decades of work experience in the Life Science field for companies like Sigma-Aldrich, Tecan and Molecular Devices he now consults European companies on how to significantly reduce their time lines in finding the right cells. He is committed to uncompromising personalized service tailored to the individual need of the respective research group for ensuring their success by automating their cell biology.